During the past decade, Reading Hospital conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 113 clinical trials were completed, i.e. on average, 93.4% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 56 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reading Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 100 trials, followed by "Radiation Therapy Oncology Group" with 52 trials sponsored, "NRG Oncology" with 21 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 105 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reading Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 154 trials as a collaborator, "NRG Oncology" with 51 trials as a collaborator, "Radiation Therapy Oncology Group" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator and "North Central Cancer Treatment Group" with 9 trials as a collaborator. Other collaborators include 98 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Reading Hospital" are "Breast Cancer" (18 trials), "Head and Neck Cancer" (13 trials), "Lung Cancer" (13 trials), "Prostate Cancer" (13 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Reading Hospital" in a lesser frequency.

Most popular intervention types in "Reading Hospital" are "Drug" (232 trials), "Other" (142 trials), "Radiation" (113 trials), "Biological" (100 trials) and "Procedure" (65 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (74 trials), "Quality-of-Life Assessment" (62 trials), "radiation therapy" (42 trials), "Paclitaxel" (36 trials) and "Questionnaire Administration" (31 trials). Other intervention names were less common.

The vast majority of trials in "Reading Hospital" are 228 trials for "All" genders, 66 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Reading Hospital". undefined are not yet recruiting, 44 are recruiting, 100 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 137 completed trials in Reading Hospital, 5 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Reading Hospital, 17 "Phase 1" clinical trials were conducted, 129 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 22 trials that are defined as “Not Applicable".

Reading Hospital has several departments that took part in Clinical trials: "St. Christopher's Hospital for Children" - 249 trials, "McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center" - 58 trials, "Digestive Disease Associates, LTD" - 5 trials, "Berks Hematology Oncology" - 4 trials, "RPS Infectious Diseases" - 3 trials, "Center For Sleep Medicine at Chestnut Hill Hospital" - 2 trials